SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%Nov 5 1:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mesaone who wrote (1023)6/15/1998 3:21:00 AM
From: Stephen How  Read Replies (1) of 1432
 
mesaone,

I don't think submitting the pre-clinical rabbit XO reperfusion injury papers will help Hextend&reg make a case as an albumin replacement. Neither will the Phase III trial posters.

Currently, there are no limits on the daily dosage for Hespan&reg. The hetastarch limits are set by the doctors.

I think that the new rule may be more disadvantageous to Pentalyte&reg than anything else. I had been posting that Abbott/Biotime would have the only pentastarch approved for volume expansion in the US, when approved. However, if the new rules go into effect, it might be very easy for Dupont to bring Pentaspan&reg into the market, as it has been used as an albumin replacement in Canada since 1993.

--

Rule 144, of course, is a legal exception for selling by affiliates. The Segalls and Waitz had held met the 2 year holding period. I'm just posting it in response to the claim that "the insiders haven't sold a share". It could be the case, but the margin account is a way around that. I'm not sure if Mont Sec would sell the securities bought using the BTIM collateral, or if they would sell the BTIM, under a margin call. I don't think they're exempt from the "short-swing" rule. If they have made $ using inside information in these accounts, they could be forced to give the proceeds back to the company (there is a 6-month window?).

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext